1887

Chapter 3.4 : Blood Cultures

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Blood Cultures, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818814/9781555818814_Chap3.4-1.gif /docserver/preview/fulltext/10.1128/9781555818814/9781555818814_Chap3.4-2.gif

Abstract:

When bacteria or fungi overcome the host’s normal defense mechanisms and enter the bloodstream through the lymphatics or from extravascular sites, they can quickly disseminate throughout the body, causing severe illness. In addition, the by-products of their metabolism can lead to septic shock, among the most serious complications of infectious diseases. Laboratory diagnosis of bacteremia and fungemia depends on blood cultures, which are probably the most important cultures performed by the microbiology laboratory. Because the culture methods are so sensitive, the procedure must be carefully controlled beginning at the preanalytical stage (collection), to avoid the misinterpretation of a procurement-associated skin commensal microorganism as an agent of infection.

Citation: Leber A. 2016. Blood Cultures, p 3.4.1.1-3.4.2.6. In Clinical Microbiology Procedures Handbook, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818814.ch3.4
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555818814.chap3.4
1. Ilstrup DM, Washington JAII. 1983. The importance of volume of blood cultured in the detection of bacteremia and fungemia. Diagn Microbiol Infect Dis 1:107110.
2. Kellogg JA, Ferrentino FL, Liss J, Shapiro SL, Bankert DA. 1994. Justification and implementation of a policy requiring two blood cultures when one is ordered. Lab Med 25:323330.
3. Kellogg JA, Manzella JP, Bankert DA. 2000. Frequency of low-level bacteremia in children from birth to fifteen years of age. J Clin Microbiol 38:21812185.
4. Li J, Plorde JJ, Carlson LG. 1994. Effects of volume and periodicity on blood cultures. J Clin Microbiol 32:28292831.
5. Weinstein MP, Mirrett S, Wilson ML, Reimer LG, Reller LB. 1994. Controlled evaluation of 5 versus 10 milliliters of blood cultured in aerobic BacT/Alert blood culture bottles. J Clin Microbiol 32:21032106.
6. Reimer LG, Wilson ML, Weinstein MP. 1997. Update on detection of bacteremia and fungemia. Clin Microbiol Rev 10:444465.
7. Baron EJ, Weinstein MP, Dunne WMJr, Yagupsky P, Welch DF, Wilson DM. 2005. Cumitech 1C, Blood Cultures IV. Coordinating ed, Baron EJ. ASM Press, Washington, DC.
8. Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RBJr, Bourbeau P, Carroll KC, Kehl SC, Dunne WM, Robinson-Dunn B, Schwartzman JD, Chapin KC, Snyder JW, Forbes BA, Patel R, Rosenblatt JE, Pritt BS. 2013. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis 57:e22e121.
9. Riedel S, Bourbeau P, Swartz B, Brecher S, Carroll KC, Stamper PD, Dunne WM, McCardle T, Walk N, Fiebelkorn K, Sewell D, Richter SS, Beekmann S, Doern GV. 2008. Timing of specimen collection for blood cultures from febrile patients with bacteremia. J Clin Microbiol 46:13811385.
10. Waltzman ML, Harper M. 2001. Financial and clinical impact of false-positive blood culture results. Clin Infect Dis 33:296299.
11. Blot F, Nitenberg G, Chachaty E, Raynard B, Germann N, Antoun S, Laplanche A, Brun-Buisson C, Tancrede C. 1999. Diagnosis of catheter-related bacteremia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 354:10711077.
12. Weinstein MP, Reller B. 2002. Commercial blood culture systems and methods, p 1221. In Truant AL (ed), Manual of Commercial Methods in Microbiology. ASM Press, Washington, DC.
13. Cornish N, Kirkley BA, Easley KA, Washington JA. 1998. Reassessment of the incubation time in a controlled clinical comparison of the BacT/Alert aerobic FAN bottle and standard anaerobic bottle used aerobically for the detection of bloodstream infections. Diagn Microbiol Infect Dis 32:17.
14. Cornish N, Kirkley BA, Easley KA, Washington JA. 1999. Reassessment of the routine anaerobic culture and incubation time in the BacT/Alert FAN blood culture bottles. Diagn Microbiol Infect Dis 35:9399.
15. James PA, Al-Shafi KM. 2000. Clinical value of anaerobic blood culture: a retrospective analysis of positive patient episodes. J Clin Pathol 53:231233.
16. Wilson ML, Weinstein MP, Mirrett S, Reimer LG, Feldman RJ, Chuard CR, Reller LB. 1995. Controlled evaluation of BacT/Alert standard anaerobic and FAN anaerobic blood culture bottles for detection of bacteremia and fungemia. J Clin Microbiol 33:22652270.
17. Evangelista AT, Truant AL, Bourbeau PP. 2002. Rapid systems and instruments for the identification of bacteria, p 2249. In Truant AL (ed), Manual of Commercial Methods in Microbiology. ASM Press, Washington, DC.
18. Patel R. 2013. Matrix-assisted laser desorption ionization-time of flight mass spectrometry in clinical microbiology. Clin Infect Dis 57:564572.
19. CLSI. 2004. Quality Assurance for Commercially Prepared Microbiological Culture Media, 3rd ed. Approved standard M22-A3. CLSI, Wayne, PA.
20. Pien BC, Sundaram P, Raoof N, Costa SF, Mirrett S, Woods CW, Reller LB, Weinstein MP. 2010. The clinical and prognostic importance of positive blood cultures in adults. Am J Med 123:819828.
21. Mirrett S, Weinstein MP, Reimer LG, Wilson ML, Reller LB. 2001. Relevance of the number of positive bottles in determining clinical significance of coagulase-negative staphylococci in blood cultures. J Clin Microbiol 39:32793281.
22. Gilligan PH. 2013. Blood culture contamination: a clinical and financial burden. Infect Control Hosp Epidemiol 34:2223.
23. Hardy DJ, Hulbert BB, Migneault PC. 1992. Time to detection of positive BacT/Alert blood cultures and lack of need for routine subculture of 5- to 7-day negative cultures. J Clin Microbiol 30:27432745.
24. Wolk DM, Struelens MJ, Pancholi P, Davis T, Della-Latta P, Fuller D, Picton E, Dickenson R, Denis O, Johnson D, Chapin K. 2009. Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA/SA skin and soft tissue and blood culture assays. J Clin Microbiol 47:823826.
25. Oliveira K, Procop GW, Wilson D, Coull J, Stender H. 2002. Rapid identification of Staphylococcus aureus from blood cultures by fluorescence in situ hybridization with peptide nucleic acid probes. J Clin Microbiol 40:247251.
26. Wojewoda CM, Sercia L, Navas M, Tuohy M, Wilson D, Hall GS, Procop GW, Richter SS. 2013. Evaluation of the Verigene Gram-positive blood culture nucleic acid test for rapid detection of bacteria and resistance determinants. J Clin Microbiol 51:20722076.
27. Teong HH, Leo YS, Wong SY, Sng LH, Ding ZP. 2000. Case report of Staphylococcus lugdunensis native valve endocarditis and review of the literature. Ann Acad Med Singapore 29:673677.
28. CLSI. 2015. Performance Standards for Antimicrobial Susceptibility Testing. Twenty-fifth informational supplement. Approved standard M100-S25. CLSI, Wayne, PA.
29. Hall L, Le Febre KM, Deml SM, Wohlfiel SL, Wengenack NL. 2012. Evaluation of the Yeast Traffic Light PNA FISH probes for identification of Candida species from positive blood cultures. J Clin Microbiol 50:14461448.
30. Heil EL, Daniels LM, Long DM, Rodino KG, Weber DJ, Miller MB. 2012. Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections. Am J Health Syst Pharm 69:19101914.
31. Sogaard M, Norgaard M, Schonheyder HC. 2007. First notification of positive blood cultures and the high accuracy of the Gram stain report. J Clin Microbiol 45:11131117.
32. Bouza E, Sousa D, Munoz P, Rodriguez-Creixems M, Fron C, Lechuz JG. 2004. Bloodstream infections: a trial of the impact of different methods of reporting positive blood culture results. Clin Infect Dis 39:11611169.
33. Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, Reller LB. 1997. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 24:584602.
34. York MK. 1990. Bacillus species pseudobacteremia in AIDS patients traced to contaminated gloves in blood collection. J Clin Microbiol 28:21142116.
35. Becker K, von Eiff C. 2011. Staphylococcus, Micrococcus, and other catalase-positive organisms p 309. In Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW (ed) Manual of Clinical Microbiology. ASM Press, Washington, DC.
1. Reimer LG, Wilson ML, Weinstein MP. 1997. Update on detection of bacteremia and fungemia. Clin Microbiol Rev 10:444465.
2. Marcon MJ, Powell DA. 1992. Human infections due to Malassezia spp. Clin Microbiol Rev 5:101119.
3. Weyant RS, Moss CW, Weaver RE, Hollis DG, Jordan JG, Cook EC, Daneshvar MI. 1995. Identification of Unusual Pathogenic Gram-Negative Aerobic and Facultatively Anaerobic Bacteria, 2nd ed. Williams & Wilkins, Baltimore, MD.
4. Crump JA, Morrissey AB, Ramadhani HO, Njau BN, Maro VP, Reller LB. 2011. Controlled comparison of BacT/Alert MB system, manual Myco/F lytic procedure, and isolator 10 system for diagnosis of Mycobacterium tuberculosis bacteremia. J Clin Microbiol 49:30543057.
5. Wasilauskas BL, Morrell RMJr. 1997. Isolator component responsible for inhibition of Mycobacterium avium-M. intracellulare in BACTEC 12B medium. J Clin Microbiol 35:588590.
6. Zucol F, Ammann RA, Berger C, Aebi C, Altwegg M, Niggli FK, Nadal D. 2006. Real-time quantitative broad-range PCR assay for detection of the 16S rRNA gene followed by sequencing for species identification. J. Clin. Microbiol. 44:27502759.
7. Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, Maurin M, Celard M, Mainardi JL, Caus T, Collart F, Habib G, Raoult D. 2010. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis 51:131140.
43. Brouqui P, Raoult D. 2001. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev 14:177207.
1. Isenberg HD. 1983. Clinical laboratory comparison of the lysis-centrifugation blood culture technique with radiometric and broth approaches, p 3854. In Balows A, Sonnenwirth A (ed), Bacteremia—Laboratory and Clinical Aspects. Charles C Thomas, Springfield, IL.
2. Henry NK, McLimans CA, Wright AJ, Thompson RL, Wilson WR, Washington JAII. 1983. Microbiological and clinical evaluation of the Isolator lysis-centrifugation blood culture tube. J Clin Microbiol 17:864869.
3. Arpi M, Gahrn-Hansen B, Rosdahl VT. 1988. Contaminating coagulase-negative staphylococci isolated in a lysis-centrifugation (Isolator) blood culture system. Application of different epidemiological markers for deduction of mode of contamination. APMIS 96:611617.
4. Thomson RBJr, Vanzo SJ, Henry NK, Guenther KL, Washington JAII. 1984. Contamination of cultures processed with the Isolator lysis-centrifugation blood culture tube. J Clin Microbiol 19:9799.
1. Alexander BD, Ashley ED, Reller LB, Reed SD. 2006. Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures. Diagn Microbiol Infect Dis 54:277282.
2. Forrest GN, Roghmann MC, Toombs LS, Johnson JK, Weekes E, Lincalis DP, Venezia RA. 2008. Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob Agents Chemother 52:35583563.
3. Heil EL, Daniels LM, Long DM, Rodino KG, Weber DJ, Miller MB. 2012. Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections. Am J Health Syst Pharm 69:19101914.
1. Parta M, Goebel M, Thomas J, Matloobi M, Stager C, Musher DM. 2010. Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results. Infect Control Hosp Epidemiol 31:10431048.
2. Wolk DM, Struelens MJ, Pancholi P, Davis T, Della-Latta P, Fuller D, Picton E, Dickenson R, Denis O, Johnson D, Chapin K. 2009. Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA/SA skin and soft tissue and blood culture assays. J Clin Microbiol 47:823826.
3. Blaschke AJ, Heyrend C, Byington CL, Fisher MA, Barker E, Garrone NF, Thatcher SA, Pavia AT, Barney T, Alger GD, Daly JA, Ririe KM, Ota I, Poritz MA. 2012. Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system. Diagn Microbiol Infect Dis 74:349355.
1. Suppli M, Aabenhus R, Harboe ZB, Andersen LP, Tvede M, Jensen JU. 2011. Mortality in enterococcal bloodstream infections increases with inappropriate antimicrobial therapy. Clin Microbiol Infect 17:10781083.
2. Buchan BW, Ginocchio CC, Manii R, Cavagnolo R, Pancholi P, Swyers L, Thomson RBJr, Anderson C, Kaul K, Ledeboer NA. 2013. Multiplex identification of gram-positive bacteria and resistance determinants directly from positive blood culture broths: evaluation of an automated microarray-based nucleic acid test. PLoS Med 10(7):e1001478.
3. Alby K, Daniels LM, Weber DJ, Miller MB. 2013. Development of a treatment algorithm for streptococci and enterococci from positive blood cultures identified with the Verigene Gram-positive culture assay. J Clin Microbiol 51:38693871.
1. Guzel AB, Ilkit M, Akar T, Burgut R, Demir SC. 2011. Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species. Med Mycol 49:1625.
2. Chihara S, Hayden MK, Minogue-Corbett E, Singh K. 2009. Shortened time to identify Staphylococcus species from blood cultures and methicillin resistance testing using CHROMagar. Int J Microbiol 2009:636502.
3. Denys GA, Renzi PB, Koch KM, Wissel CM. 2013. Three-way comparison of BBL CHROMagar MRSA II, MRSASelect, and spectra MRSA for detection of methicillin-resistant Staphylococcus aureus isolates in nasal surveillance cultures. J Clin Microbiol 51:202205.
1. Biswas S, Rolain JM. 2010. Bartonella infection: treatment and drug resistance. Future Microbiol 5:17191731. doi:10.2217/fmb.10.133.
2. Angelakis E, Billeter SA, Breitschwerdt EB, Chomel BB, Raoult D. 2010. Potential for tick-borne bartonelloses. Emerg Infect Dis 16:385391.
3. Telford SRIII, Wormser GP. 2010. Bartonella spp. transmission by ticks not established. Emerg Infect Dis 16:379384.
4. Angelakis E, Pulcini C, Waton J, Imbert P, Socolovschi C, Edouard S, Dellamonica P, Raoult D. 2010. Scalp eschar and neck lymph-adenopathy caused by Bartonella henselae after tick bite. Clin Infect Dis 50:549551. doi:10.1086/650172.
5. Dehio C, Sauder U, Hiestand R. 2004. Isolation of Bartonella schoenbuchensis from Lipoptena cervi, a blood-sucking arthropod causing deer ked dermatitis. J Clin Microbiol 42:53205323.
6. Jacomo V, Kelly PJ, Raoult D. 2002. Natural history of Bartonella infections (an exception to Koch’s postulate). Clin Diagn Lab Immunol 9:818.
7. Rolain JM, Brouqui P, Koehler JE, Maguina C, Dolan MJ, Raoult D. 2004. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother 48:19211933.
8. Angelakis E, Roux V, Raoult D, Rolain JM. 2009. Real-time PCR strategy and detection of bacterial agents of lymphadenitis. Eur J Clin Microbiol Infect Dis 28:13631368.
9. Angelakis E, Lepidi H, Canel A, Rispal P, Perraudeau F, Barre I, Rolain JM, Raoult D. 2008. Human case of Bartonella alsatica lymphadenitis. Emerg Infect Dis 14:19511953.
10. Rolain JM, Lepidi H, Zanaret M, Triglia JM, Michel G, Thomas PA, Texereau M, Stein A, Romaru A, Eb F, Raoult D. 2006. Lymph node biopsy specimens and diagnosis of cat-scratch disease. Emerg Infect Dis 12:13381344.
11. Mascarelli PE, Iredell JR, Maggi RG, Weinberg G, Breitschwerdt EB. 2011. Bartonella species bacteremia in two patients with epithelioid hemangioendothelioma. J Clin Microbiol 49:40064012. doi:10.1128/JCM.05527-11.
12. Kosoy M, Morway C, Sheff KW, Bai Y, Colborn J, Chalcraft L, Dowell SF, Peruski LF, Maloney SA, Baggett H, Sutthirattana S, Sidhirat A, Maruyama S, Kabeya H, Chomel BB, Kasten R, Popov V, Robinson J, Kruglov A, Petersen LR. 2008. Bartonella tamiae sp. nov., a newly recognized pathogen isolated from three human patients from Thailand. J Clin Microbiol 46:772775.
13. Eremeeva ME, Gerns HL, Lydy SL, Goo JS, Ryan ET, Mathew SS, Ferraro MJ, Holden JM, Nicholson WL, Dasch GA, Koehler JE. 2007. Bacteremia, fever, and splenomegaly caused by a newly recognized bartonella species. N Engl J Med 356:23812387. doi:10.1056/NEJMoa065987.
14. Welch DF, Carroll KC, Hofmeister EK, Persing DH, Robison DA, Steigerwalt AG, Brenner DJ. 1999. Isolation of a new subspecies, Bartonella vinsonii subsp. arupensis, from a cattle rancher: identity with isolates found in conjunction with Borrelia burgdorferi and Babesia microti among naturally infected mice. J Clin Microbiol 37:25982601.
15. Breitschwerdt EB, Maggi RG, Lantos PM, Woods CW, Hegarty BC, Bradley JM. 2010. Bartonella vinsonii subsp. berkhoffii and Bartonella henselae bacteremia in a father and daughter with neurological disease. Parasit Vectors 3:29. doi:10.1186/1756-3305-3-29.
16. Maggi RG, Kosoy M, Mintzer M, Breitschwerdt EB. 2009. Isolation of Candidatus Bartonella melophagi from human blood. Emerg Infect Dis 15:6668. doi:10.3201/eid1501.081080.
17. Birtles RJ, Fry NK, Ventosilla P, Caceres AG, Sanchez E, Vizcarra H, Raoult D. 2002. Identification of Bartonella bacilliformis genotypes and their relevance to epidemiological investigations of human bartonellosis. J Clin Microbiol 40:36063612.
18. Maco V, Maguina C, Tirado A, Maco V, Vidal JE. 2004. Carrion’s disease (Bartonellosis bacilliformis) confirmed by histopathology in the High Forest of Peru. Rev Inst Med Trop Sao Paulo 46:171174.
19. Sanchez CN, Ugarte-Gil CA, Solorzano N, Maguina C, Pachas P, Blazes D, Bailey R, Mabey D, Moore M. 2012. Bartonella bacilliformis: a systematic review of the literature to guide the research agenda for elimination. PLoS Negl Trop Dis. 6:e1819. doi:10.1371/journal.pntd.0001819.
20. Blazes DL, Mullins K, Smoak BL, Jiang J, Canal E, Solorzano N, Hall E, Meza R, Maguina C, Myers T, Richards AL, Laughlin L. 2013. Novel Bartonella agent as cause of verruga peruana. Emerg Infect Dis 19:11111114. doi:10.3201/eid1907.121718.
21. Dehio C. 2003. Recent progress in understanding Bartonella-induced vascular proliferation. Curr Opin Microbiol 6:6165. doi:10.1016/S1369-5274(03)00006-7.
22. Maguina Vargas C. 1998. Bartonellosis o enfermedad de carrion. Nuevos aspectos de una vieja enfermedad. A.F.A. Editores Importadores, Lima, Peru.
23. Prutsky G, Domecq JP, Mori L, Bebko S, Matzumura M, Sabouni A, Shahrour A, Erwin PJ, Boyce TG, Montori VM, Malaga G, Murad MH. 2013. Treatment outcomes of human bartonellosis: a systematic review and meta-analysis. Int J Infect Dis 17:e811e819. doi:10.1016/j.ijid.2013.02.016.
24. La Scola B, Raoult D. 1999. Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993 to 1998). J Clin Microbiol 37:18991905.
25. Angelakis E, Edouard S, La Scola B, Raoult D. 2010. Bartonella henselae in skin biopsy specimens of patients with cat-scratch disease. Emerg Infect Dis 16:19631965.
26. Fournier PE, Mainardi JL, Raoult D. 2002. Value of microimmunofluorescence for diagnosis and follow-up of Bartonella endocarditis. Clin Diagn Lab Immunol 9:795801.
27. Lepidi H, Coulibaly B, Casalta JP, Raoult D. 2006. Autoimmunohistochemistry: a new method for the histologic diagnosis of infective endocarditis. J Infect Dis 193:17111717.
28. Safont M, Angelakis E, Richet H, Lepidi H, Fournier PE, Drancourt M, Raoult D. 29 January 2014. Bacterial lymphadenitis at a major referral hospital in France from 2008 to 2012. J Clin Microbiol doi:10.1128/JCM.03491-13.
29. Matar GM, Koehler JE, Malcolm G, Lambert-Fair MN, Tappero J, Hunter SB, Swaminathan B. 1999. Identification of Bartonella species directly in clinical specimens by PCR-restriction fragment length polymorphism analysis of a 16S rRNA gene fragment. J Clin Microbiol 37:40454047.
30. Spach DH, Kanter AS, Dougherty MJ, Larson AM, Coyle MB, Brenner DJ, Swaminathan B, Matar GM, Welch DF, Root RK, Stamm WE. 1995. Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism. N Engl J Med 332:424428.
31. Koehler JE, Quinn FD, Berger TG, Leboit PE, Tappero JW. 1992. Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis. N Engl J Med 327:16251631.
32. Kosek M, Lavarello R, Gilman RH, Delgado J, Maguina C, Verastegui M, Lescano AG, Mallqui V, Kosek JC, Recavarren S, Cabrera L. 2000. Natural history of infection with Bartonella bacilliformis in a nonendemic population. J Infect Dis 182:865872. doi:10.1086/315797.
33. Walker TS, Winkler HH. 1981. Bartonella bacilliformis: colonial types and erythrocyte adherence. Infect. Immun. 31:480486.
34. Weinman D. 1981. Bartonellosis and anemias associated with bartonella-like structures, p 235248. In Balows A, Hausler WJJr (ed), Diagnostic Procedures for Bacterial, Mycotic and Parasitic Infections, 6th ed. American Public Health Association, Washington, DC.
35. Knobloch J, Solano L, Alvarez O, Delgado E. 1985. Antibodies to Bartonella bacilliformis as determined by fluorescence antibody test, indirect haemagglutination and ELISA. Trop Med Parasitol 36:183185.
36. La Scola B, Zeaiter Z, Khamis A, Raoult D. 2003. Gene-sequence-based criteria for species definition in bacteriology: the Bartonella paradigm. Trends Microbiol 11:318321.
96. Brouqui P, Raoult D. 2001. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev 14:177207.
97. Daly JS, Worthington MG, Brenner DJ, Moss CW, Hollis DG, Weyant RS, Steigerwalt AG, Weaver RE, Daneshvar MI, O’Connor SP. 1993. Rochalimaea elizabethae sp. nov. isolated from a patient with endocarditis. J Clin Microbiol 31:872881.
98. Ellis BA, Rotz LD, Leake JAD, Samalvides F, Bernable J, Ventura G, Padilla C, Villaseca P, Beati L, Regnery R, Childs JE, Olsen JG, Carrillo CP. 1999. An outbreak of acute bartonellosis (Oroya fever) in the Urubamba region of Peru, 1998. Am J Trop Med Hyg 61:344349.

Tables

Generic image for table
Table 3.4.1–1

Blood volume for culture from pediatric patients

Citation: Leber A. 2016. Blood Cultures, p 3.4.1.1-3.4.2.6. In Clinical Microbiology Procedures Handbook, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818814.ch3.4
Generic image for table
Table 3.4.1–2

Visible signs of growth caused by organisms commonly encountered in blood cultures

Citation: Leber A. 2016. Blood Cultures, p 3.4.1.1-3.4.2.6. In Clinical Microbiology Procedures Handbook, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818814.ch3.4
Generic image for table
Table 3.4.1–3

Initial processing and reporting results from positive blood culture bottles

Citation: Leber A. 2016. Blood Cultures, p 3.4.1.1-3.4.2.6. In Clinical Microbiology Procedures Handbook, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818814.ch3.4
Generic image for table
Table 3.4.1–4

Day 2 positive blood culture interpretation and reporting results

Citation: Leber A. 2016. Blood Cultures, p 3.4.1.1-3.4.2.6. In Clinical Microbiology Procedures Handbook, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818814.ch3.4

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error